inVentiv Partnership Aims to Bring Top Biosimilars to Market
inVentiv Health and Oncobiologics are employing a unique risk-sharing partnership to bring a number of the biggest blockbuster biologics to market as biosimilars.
inVentiv Health and Oncobiologics are employing a unique risk-sharing partnership to bring a number of the biggest blockbuster biologics to market as biosimilars.
CMO Pharma Tech Industries (PTI) will invest more than $5M to expand its production facility in Union, Missouri, which makes ingestible powders.
CRO Covance is looking to help its biopharmaceutical and medical device clients manage their contract terms and associated payments better as some companies are losing almost 5% of US revenue from insufficient processes and contract management systems.
Sales and profit were down in Q2 for Ranbaxy but the firm has signed an agreement with the Malaysian Government to build a new manufacturing facility.